Effectiveness of Saccharomyces boulardii in a rat model of colitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

381

HTML

3208

Figures (1-2)

230

Tables (1-3)

233

Sum=4052

Nov 28, 2012 (publication date) through Dec 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 28, 2012; 18(44): 6452-6460
Published online Nov 28, 2012. doi: 10.3748/wjg.v18.i44.6452

Table 1 Study groups

TNBS: Trinitrobenzene sulfonic acid; S. boulardii: Saccharomyces boulardii; MP: Methyl prednisolone.

Table 2 Disease activity index analysis¹

¹Data are reported by Murthy et al [11].

Table 3 Changes in body weight in the experimental groups

The results are shown as the mean ± SD.

^aP = 0.02 vs Saccharomyces boulardii (S. boulardii) + methyl prednisolone (MP);

^bP = 0.01 vs MP. TNBS: Trinitrobenzene sulfonic acid.

Citation: Soyturk M, Saygili SM, Baskin H, Sagol O, Yilmaz O, Saygili F, Akpinar H. Effectiveness of Saccharomyces boulardii in a rat model of colitis. World J Gastroenterol 2012; 18(44): 6452-6460
URL: https://www.wjgnet.com/1007-9327/full/v18/i44/6452.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i44.6452